 |
ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing the human COL7A1 gene. |
|---|---|
| Trade Name | |
| Orphan Indication | Dystrophic epidermolysis bullosa |
| USA Market Approval | USA |
| USA Designation Date | 2017-05-24 00:00:00 |
| Sponsor | Abeona Therapeutics;6555 Carnegie Blvd, Suite 401;Cleveland, Ohio, 44103 |
